Patents by Inventor Mitsuhisa Yamano

Mitsuhisa Yamano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10336864
    Abstract: The present invention relates to a graft copolymer of a poly(amino acid) or a salt thereof and a hydrophobic primary amine compound or a salt thereof (e.g., a graft copolymer (?-PGA-PAE) of poly(?-glutamic acid) (?-PGA) and phenylalanine ethyl ester (PAE)), an ionized graft copolymer of a poly(amino acid) or a salt thereof and a hydrophobic primary amine compound or a salt thereof, nanoparticles containing the ionized graft copolymer, and a production method thereof. The nanoparticles acquired in this way are useful as an adjuvant for producing a vaccine.
    Type: Grant
    Filed: October 9, 2017
    Date of Patent: July 2, 2019
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Mitsuhisa Yamano, Toshiaki Nagata, Hideki Saitoh
  • Publication number: 20180079741
    Abstract: The present invention provides a method of efficiently producing an optically active 6-(3-aminopiperidin-1-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine derivative. The optically active piperidine-3-carboxamide or a derivative thereof, which is obtained by subjecting 1,4,5,6-tetrahydropyridine-3-carboxamide or a derivative thereof to an asymmetric reduction in the presence of a catalyst, is used as an intermediate.
    Type: Application
    Filed: October 18, 2017
    Publication date: March 22, 2018
    Applicant: Takeda Pharmaceuticals Company Limited
    Inventors: Masatoshi Yamada, Sayuri Hirano, Ryoji Tsuruoka, Mitsuhisa Yamano
  • Publication number: 20180044472
    Abstract: The present invention relates to a graft copolymer of a poly(amino acid) or a salt thereof and a hydrophobic primary amine compound or a salt thereof (e.g., a graft copolymer (?-PGA-PAE) of poly(?-glutamic acid) (?-PGA) and phenylalanine ethyl ester (PAE)), an ionized graft copolymer of a poly(amino acid) or a salt thereof and a hydrophobic primary amine compound or a salt thereof, nanoparticles containing the ionized graft copolymer, and a production method thereof. The nanoparticles acquired in this way are useful as an adjuvant for producing a vaccine.
    Type: Application
    Filed: October 9, 2017
    Publication date: February 15, 2018
    Inventors: Mitsuhisa YAMANO, Toshiaki NAGATA, Hideki SAITOH
  • Patent number: 9815938
    Abstract: The present invention relates to a graft copolymer of a poly(amino acid) or a salt thereof and a hydrophobic primary amine compound or a salt thereof (e.g., a graft copolymer (?-PGA-PAE) of poly(?-glutamic acid) (?-PGA) and phenylalanine ethyl ester (PAE)), an ionized graft copolymer of a poly(amino acid) or a salt thereof and a hydrophobic primary amine compound or a salt thereof, nanoparticles containing the ionized graft copolymer, and a production method thereof. The nanoparticles acquired in this way are useful as an adjuvant for producing a vaccine.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: November 14, 2017
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Mitsuhisa Yamano, Toshiaki Nagata, Hideki Saitoh
  • Patent number: 9809569
    Abstract: The present invention provides a method of efficiently producing an optically active 6-(3-aminopiperidin-1-yl)-2,4-dioxo -1,2,3,4-tetrahydropyrimidine derivative. The optically active piperidine-3-carboxamide or a derivative thereof, which is obtained by subjecting 1,4,5,6-tetrahydropyridine -3-carboxamide or a derivative thereof to an asymmetric reduction in the presence of a catalyst, is used as an intermediate.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: November 7, 2017
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Masatoshi Yamada, Sayuri Hirano, Ryoji Tsuruoka, Mitsuhisa Yamano
  • Publication number: 20170081305
    Abstract: The present invention provides a method of efficiently producing an optically active 6-(3-aminopiperidin-1-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine derivative. The optically active piperidine-3-carboxamide or a derivative thereof, which is obtained by subjecting 1,4,5,6-tetrahydropyridine-3-carboxamide or a derivative thereof to an asymmetric reduction in the presence of a catalyst, is used as an intermediate.
    Type: Application
    Filed: March 13, 2015
    Publication date: March 23, 2017
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Masatoshi Yamada, Sayuri HIRANO, Ryoji TSURUOKA, Mitsuhisa YAMANO
  • Publication number: 20160177032
    Abstract: The present invention relates to a graft copolymer of a poly(amino acid) or a salt thereof and a hydrophobic primary amine compound or a salt thereof (e.g., a graft copolymer (?-PGA-PAE) of poly(?-glutamic acid) (?-PGA) and phenylalanine ethyl ester (PAE)), an ionized graft copolymer of a poly(amino acid) or a salt thereof and a hydrophobic primary amine compound or a salt thereof, nanoparticles containing the ionized graft copolymer, and a production method thereof. The nanoparticles acquired in this way are useful as an adjuvant for producing a vaccine.
    Type: Application
    Filed: June 25, 2014
    Publication date: June 23, 2016
    Inventors: Mitsuhisa YAMANO, Toshiaki NAGATA, Hideki SAITOH
  • Patent number: 9238667
    Abstract: [Problem] Provision of a superior rhodium catalyst and a production method of amine compound.
    Type: Grant
    Filed: March 28, 2013
    Date of Patent: January 19, 2016
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Mitsuhisa Yamano, Masatoshi Yamada, Hirotsugu Usutani
  • Patent number: 8981147
    Abstract: The present invention provides a novel ligand represented by the following formula and a novel transition metal complex having the ligand, which shows superior enantioselectivity and catalytic efficiency, particularly high catalyst activity, in various asymmetric synthesis reactions. A transition metal complex having, as a ligand, a compound represented by the formula wherein R4 is a hydrogen atom or a C1-6 alkyl group optionally having substituent(s), and R5 and R6 are each a C1-6 alkyl group optionally having substituent(s), or the formula is a group represented by the formula wherein ring B is a 3- to 8-membered ring optionally having substituent(s).
    Type: Grant
    Filed: February 19, 2014
    Date of Patent: March 17, 2015
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Mitsuhisa Yamano, Mitsutaka Goto, Shinji Kawaguchi, Masatoshi Yamada, Jun-ichi Kawakami
  • Publication number: 20150051416
    Abstract: [Problem] Provision of a superior rhodium catalyst and a production method of amine compound.
    Type: Application
    Filed: March 28, 2013
    Publication date: February 19, 2015
    Inventors: Mitsuhisa Yamano, Masatoshi Yamada, Hirotsugu Usutani
  • Patent number: 8952185
    Abstract: Provided is a production method of an optically active dihydrobenzofuran derivative. A production method of an optically active form of a compound represented by the formula: wherein each symbol is as defined in the specification, or a salt thereof and the like.
    Type: Grant
    Filed: February 16, 2012
    Date of Patent: February 10, 2015
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Mitsuhisa Yamano, Mitsutaka Goto, Takahiro Konishi
  • Publication number: 20140171655
    Abstract: The present invention provides a novel ligand represented by the following formula and a novel transition metal complex having the ligand, which shows superior enantioselectivity and catalytic efficiency, particularly high catalyst activity, in various asymmetric synthesis reactions. A transition metal complex having, as a ligand, a compound represented by the formula wherein R4 is a hydrogen atom or a C1-6 alkyl group optionally having substituent(s), and R5 and R6 are each a C1-6 alkyl group optionally having substituent(s), or the formula is a group represented by the formula wherein ring B is a 3- to 8-membered ring optionally having substituent(s).
    Type: Application
    Filed: February 19, 2014
    Publication date: June 19, 2014
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Mitsuhisa YAMANO, Mitsutaka GOTO, Shinji KAWAGUCHI, Masatoshi YAMADA, Jun-ichi KAWAKAMI
  • Patent number: 8691718
    Abstract: The present invention provides a novel ligand represented by the following formula and a novel transition metal complex having the ligand, which shows superior enantioselectivity and catalytic efficiency, particularly high catalyst activity, in various asymmetric synthesis reactions. A transition metal complex having, as a ligand, a compound represented by the formula wherein R4 is a hydrogen atom or a C1-6 alkyl group optionally having substituent(s), and R5 and R6 are each a C1-6 alkyl group optionally having substituent(s), or the formula is a group represented by the formula wherein ring B is a 3- to 8-membered ring optionally having substituent(s).
    Type: Grant
    Filed: September 20, 2006
    Date of Patent: April 8, 2014
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Mitsuhisa Yamano, Mitsutaka Goto, Shinji Kawaguchi, Masatoshi Yamada, Jun-ichi Kawakami
  • Publication number: 20130345444
    Abstract: Provided is a production method of an optically active dihydrobenzofuran derivative. A production method of an optically active form of a compound represented by the formula: wherein each symbol is as defined in the specification, or a salt thereof and the like.
    Type: Application
    Filed: February 16, 2012
    Publication date: December 26, 2013
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Mitsuhisa Yamano, Mitsutaka Goto, Takeshi Kajiwara, Hiroyuki Maeda, Takahiro Konishi, Misayo Sera, Yuichiro Kondo, Seiji Yamasaki
  • Patent number: 8373007
    Abstract: Disclosed is a vinamidinium salt represented by the formula (I): [wherein R1 represents a hydrogen atom, a halogen atom, an optionally substituted hydrocarbon group or the like; R2 and R3 are the same or different and each represents a lower alkyl group, or alternatively R2 and R3 may combine together to form a ring; R4 and R5 are the same or different and each represents a lower alkyl group, or alternatively R4 and R5 may combine together to form a ring; X and Y are the same or different and each represents a bromine atom or a chlorine atom; n represents a number of not less than 2; and m represents 0 or n], and methods for synthesizing a heterocyclic ring compound using the salt.
    Type: Grant
    Filed: March 27, 2009
    Date of Patent: February 12, 2013
    Assignee: Takeda Pharmaceutical Company Ltd.
    Inventors: Mitsuhisa Yamano, Yasuhiro Sawai, Masahiro Mizuno
  • Patent number: 8053604
    Abstract: A production method of a compound represented by the formula wherein R1a, R1b, R1c, R1d, R1e, R1f, R2a, R2b, R2c, R2d, R2e and R2f are the same or different and each is a hydrogen atom and the like, and R3, R4, R5, R6, R7, R8, R9 and R10 are the same or different and each is a hydrogen atom and the like, or a salt thereof, which comprises reacting a compound represented by the formula wherein X is a leaving group and other symbols are as defined above, or a salt thereof, with a phosphine-borane complex represented by the formula wherein the symbols are as defined above, or a salt thereof, in a solvent in the presence of an amine and a nickel catalyst, is provided.
    Type: Grant
    Filed: January 27, 2010
    Date of Patent: November 8, 2011
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Mitsutaka Goto, Mitsuhisa Yamano
  • Publication number: 20110015399
    Abstract: Disclosed is a vinamidinium salt represented by the formula (I): [wherein R1 represents a hydrogen atom, a halogen atom, an optionally substituted hydrocarbon group or the like; R2 and R3 are the same or different and each represents a lower alkyl group, or alternatively R2 and R3 may combine together to form a ring; R4 and R5 are the same or different and each represents a lower alkyl group, or alternatively R4 and R5 may combine together to form a ring; X and Y are the same or different and each represents a bromine atom or a chlorine atom; n represents a number of not less than 2; and m represents 0 or n], which can be used as a general purpose reagent useful for synthesis of various nitrogen-containing heteroaromatic rings having a substituent. The vinamidinium salt has excellent storage stability and reaction selectivity. A method for synthesizing a nitrogen-containing heteroaromatic ring compound using the vinamidinium salt is also disclosed.
    Type: Application
    Filed: March 27, 2009
    Publication date: January 20, 2011
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LTD.
    Inventors: Mitsuhisa Yamano, Yasuhiro Sawai, Masahiro Mizuno
  • Publication number: 20100125153
    Abstract: A production method of a compound represented by the formula wherein R1a, R1b, R1c, R1d, R1e, R1f, R2a, R2b, R2c, R2d, R2e and R2f are the same or different and each is a hydrogen atom and the like, and R3, R4, R5, R6, R7, R8, R9 and R10 are the same or different and each is a hydrogen atom and the like, or a salt thereof, which comprises reacting a compound represented by the formula wherein X is a leaving group and other symbols are as defined above, or a salt thereof, with a phosphine-borane complex represented by the formula wherein the symbols are as defined above, or a salt thereof, in a solvent in the presence of an amine and a nickel catalyst, is provided.
    Type: Application
    Filed: January 27, 2010
    Publication date: May 20, 2010
    Inventors: Mitsutaka Goto, Mitsuhisa Yamano
  • Patent number: 7678942
    Abstract: A production method of a compound represented by the formula wherein R1a, R1b, R1c, R1d, R1e, R1f, R2a, R2b, R2c, R2d, R2e and R2f are the same or different and each is a hydrogen atom and the like, and R3, R4, R5, R6, R7, R8, R9 and R10 are the same or different and each is a hydrogen atom and the like, or a salt thereof, which comprises reacting a compound represented by the formula wherein X is a leaving group and other symbols are as defined above, or a salt thereof, with a phosphine-borane complex represented by the formula wherein the symbols are as defined above, or a salt thereof, in a solvent in the presence of an amine and a nickel catalyst, is provided.
    Type: Grant
    Filed: March 6, 2007
    Date of Patent: March 16, 2010
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Mitsutaka Goto, Mitsuhisa Yamano
  • Publication number: 20090270635
    Abstract: The present invention provides a novel ligand represented by the following formula and a novel transition metal complex having the ligand, which shows superior enantioselectivity and catalytic efficiency, particularly high catalyst activity, in various asymmetric synthesis reactions. A transition metal complex having, as a ligand, a compound represented by the formula wherein R4 is a hydrogen atom or a C1-6 alkyl group optionally having substituent(s), and R5 and R6 are each a C1-6 alkyl group optionally having substituent(s), or the formula is a group represented by the formula wherein ring B is a 3- to 8-membered ring optionally having substituent(s).
    Type: Application
    Filed: September 20, 2006
    Publication date: October 29, 2009
    Inventors: Mitsuhisa Yamano, Mitsutaka Goto, Shinji Kawaguchi, Masatoshi Yamada, Jun-ichi Kawakami